ADAPTHEALTH CORP (AHCO) Stock News
NASDAQ:AHCO - Nasdaq - US00653Q1022 - Common Stock - Currency: USD
AHCO Latest News, Press Relases and Analysis
3 Value Stocks in Hot Water
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
3 Russell 2000 Stocks in the Doghouse
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
AHCO or SYK: Which Is the Better Value Stock Right Now?
AHCO vs. SYK: Which Stock Is the Better Value Option?
Mentions: SYK
AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates
AdaptHealth (AHCO) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
AdaptHealth Corp. Announces First Quarter 2025 Results
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y
Accuray reports solid fiscal third-quarter results, witnessing growth in Product & Services revenues and reduced operating expenses.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
CAH Q3 Earnings Beat Estimates, '25 EPS View Raised, Stock Gains
Cardinal Health's third-quarter fiscal 2025 results benefit from solid Medical and Other segment revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
AdaptHealth (AHCO) Upgraded to Buy: Here's What You Should Know
AdaptHealth (AHCO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AdaptHealth Corp. Announces First Quarter 2025 Earnings Release Date and Conference Call